REBECCA DURHAM: Open Payments
NPI 1477520344 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 15 payments from 9 companies in 2025. Trend: 2023 $543 · 2024 $715 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 3 | $79 |
| Novo Nordisk Inc | 3 | $60 |
| PFIZER INC. | 2 | $41 |
| Lilly USA, LLC | 2 | $34 |
| Abbott Laboratories | 1 | $19 |
| ABBVIE INC. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $5 |
Products named: Dexcom G6 Transmitter, Ozempic, MOUNJARO, Wegovy, NURTEC ODT, ELIQUIS, FREESTYLE LIBRE 3, UBRELVY.
Industry payments across GA — which companies pay providers there.
